Has Apollo Care LLC had other FDA enforcement actions?

Yes. Argus HQ has recorded 12 total FDA actions tied to Apollo Care LLC: 0 warning letters, 11 recalls, 0 approval records, and 1 Form 483 inspection citation.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-08-19; Argus observed and indexed it on 2026-08-26.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · drug_recall · high

Apollo Care, LLC — Class II recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose V…

Name: FDA Recall Record — Apollo Care LLC
Creator: Argus HQ
Published: 2026-08-19
License: https://argushq.ai/methodology

Event date: 2026-08-19 00:00:00Z
Observed: 2026-08-26 04:20:32Z
Source ID: D-0755-2026
Payload hash: 442157f5ca16304d9a3f8d8d…

Summary

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Status: Ongoing.

Entities

Apollo Care LLC

View source record ↗

Frequently asked questions

Has Apollo Care LLC had other FDA enforcement actions?: Yes. Argus HQ has recorded 12 total FDA actions tied to Apollo Care LLC: 0 warning letters, 11 recalls, 0 approval records, and 1 Form 483 inspection citation.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-08-19; Argus observed and indexed it on 2026-08-26.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Apollo Care, LLC — Class II recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose V…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-apollo-care-llc-d-0755-2026

MLA

"Apollo Care, LLC — Class II recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose V…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-apollo-care-llc-d-0755-2026.

Chicago

Argus HQ Research. "Apollo Care, LLC — Class II recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose V…." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/events/fda-recall-apollo-care-llc-d-0755-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_apollo_care_llc_d_0755_2026_2026,
  title = {Apollo Care, LLC — Class II recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose V…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-apollo-care-llc-d-0755-2026},
  note = {Accessed: August 27, 2026}
}

Informational only. Not legal, financial, or medical advice.